Table 1. Patient and disease characteristics at baseline.
| Characteristic | Number of patients (N=40) | % |
|---|---|---|
| Sex | ||
| Male | 30 | 75.0 |
| Female | 10 | 25.0 |
| Age, years | ||
| Median | 55 | |
| Range | 33–74 | |
| Performance status (ECOG) | ||
| 0 | 7 | 17.5 |
| 1 | 29 | 72.5 |
| 2 | 4 | 10.0 |
| Disease status | ||
| Relapsed | 5 | 12.5 |
| Adjuvant chemotherapy | 3 | |
| No adjuvant chemotherapy | 2 | |
| Initially metastatic | 35 | 87.5 |
| Location | ||
| Proximal | 5 | 12.5 |
| Middle | 4 | 10.0 |
| Distal | 26 | 65.0 |
| Diffuse | 5 | 12.5 |
| Lauren classification | ||
| Intestinal | 12 | 30.0 |
| Diffuse | 28 | 70.0 |
| Number of organs involved | ||
| 1 | 5 | 12.5 |
| 2 | 7 | 17.5 |
| 3 | 17 | 42.5 |
| 4 | 7 | 17.5 |
| ⩾5 | 4 | 10.0 |
| Site of metastasis | ||
| Lymph node | 36 | 90.0 |
| Peritoneum | 21 | 52.5 |
| Liver | 16 | 40.0 |
| Others (lung, bone, and so on) | 9 | 22.5 |
ECOG, Eastern Cooperative Oncology Group.